ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,298.60
0.28%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.53
0.07%
Brent Oil
81.26
0.56%
Bitcoin
68,921.48
1.73%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Zentalis Pharmaceuticals Inc (ZNTL) Share Price

ZNTL Zentalis Pharmaceuticals Inc

11.88
0.00 (0.00%)
Pre Market
Last Updated: 09:09:56
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Zentalis Pharmaceuticals Inc NASDAQ:ZNTL NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.00 0.00 11.88 10.42 19.00 0.00 0.00   08:09:56   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -292.19M -4.1177 -2.89 843.01M
 Type  Size  Price  Time  Units 
   0.00  
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore ZNTL News
30/05/202412:00GLOBEZentalis Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
29/05/202412:16EDGAR2Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
29/05/202412:04EDGAR2Form 8-K - Current report
29/05/202412:00GLOBEZentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, M.D., to Board of Directors
23/05/202422:01GLOBEZentalis Pharmaceuticals to Present Promising Results from Phase 1 Trial of Azenosertib and Gemcitabine in Relapsed or Refractory Osteosarcoma at 2024 American Society of Clinical Oncology Annual Meeting
14/05/202412:00GLOBEZentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation Summit
07/05/202412:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Period
Draw mode
Data Downloads for ZNTL

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Zentalis Pharmaceuticals Inc Articles